SOPHiA GENETICS

This week, I climbed the sub-summit of the Mittaghorn in Saas Fee with Kevin Puylaert, one of our inspiring leaders, whose focus and determination reflect the spirit of our team. It was a moment with profound personal meaning — one I couldn’t have imagined just months ago.   Between March and April this year, I underwent four emergency spine surgeries.   Recovery has been gradual and sometimes unpredictable. My leg still isn’t fully healthy, and there were days when even walking felt impossible. Yet, step by step, I moved forward.   Resilience doesn't lie in controlling every outcome. It’s about accepting what cannot be changed and focusing on purposeful actions in the present.   This climb reminded me of the challenges 2024 has brought, both personally and professionally. For companies in our field, the landscape has been especially demanding.   While I couldn’t always be present as I’d hoped, these challenges have revealed the strength of a team, the loyalty of those who stand by you, and the power of shared purpose.   To everyone climbing their own mountains, in health, life, or business: keep moving, one deliberate step at a time. True strength is built not at the summit, but in every step taken along the way.

🌍 We are very proud to have recently joined the European Liquid Biopsy Society (ELBS), a prestigious network consisting of partners from academia and industry with the common goal of making liquid biopsy tests part of the routine standard of care! The ELBS pursues a holistic approach to tackling the challenges of clinical implementation in the liquid biopsy field. The network incorporates key players from academia, clinics, industry, and national government agencies to move this promising field forward collectively. 🧬 SOPHiA GENETICS offers a comprehensive suite of liquid biopsy applications that have helped progress oncology research and tumor mutation profiling. Liquid biopsy testing offers an alternative to solid tumor testing by isolating cell-free DNA (cfDNA) from blood plasma, which may uncover circulating tumor DNA (ctDNA). This non-invasive testing allows for cancer genomic profiling and disease monitoring. It reveals critical insights in many cases where genomic testing of tumor tissue may not be feasible due to insufficient tissue material, low quality of the obtained tissue, or the invasiveness of the procedure. 🔗 Learn more about the ELBS: https://loom.ly/3KD9Mic 🔗 Explore our liquid biopsy applications: https://loom.ly/DKKbXGQ #ELBS #LiquidBiopsy #Oncology Klaus Pantel

🌟 Our team is on site at the San Antonio Breast Cancer Symposium! Don’t miss the chance to connect with: · Guillaume Cettou, Global Head of Data Partnerships · Marion Bossy, DVM, Global Head of RWE · Thierry Colin, VP, Multimodal R&D They’re ready to discuss how SOPHiA GENETICS is transforming breast cancer research by making sense of complex data and turning it into actionable insights. 💬 Reach out to them on LinkedIn today! #SABCS #DataDrivenMedicine #BreastCancer #PrecisionOncology

🎬 A glimpse into our internship experience at SOPHiA GENETICS! 🎉   We're excited to share a sneak peek into the daily lives of our talented interns working across different departments here at SOPHiA GENETICS. From data science and #bioinformatics to product management and beyond, our interns are making valuable contributions and gaining hands-on experience that will shape their future careers.    A huge thank you to our amazing interns for being part of this journey and bringing their unique talents to the table!  🙌 We're proud to support all of our current interns and look forward to seeing the incredible impact you’ll continue to make.   Anja Sjöström, Pierre Gabioud, Tiya Mistry, Rodrigo Oliveira, Anastasiia S., Mohammed Salaymeh, Inês Nunes Aguas, Pablo Daniel Estevez Bretones, Germán Chiarelli, Dominika Malinowska, Divyansh Sethi, LeungSing Chan, Suchi Karn, Oier Cesat, Olivia Maurouzel, sacha skoczek, Jules Devillé, Nina Fillová, Lucas BRANA, Rafael Pizarro Solar #Internship #DataDrivenMedicine #BringYourLearningToLife #CareerGrowth

Last Friday’s holiday celebration in Rolle reminded me of how far we’ve come. Once just a handful of people with a vision, we’ve grown into a global force - empowering healthcare institutions across more than 70 countries from our offices in Switzerland, the U.S., and France. Today, our executive team stepped onto the ice to test our aim as a collective. Our ice stick precision shooting symbolized the focus and agility behind every stride we take toward more equitable care. To Ross, Manuela, Philippe, Zhenyu, Daan, Abhimanyu, Kevin, George, and Kellen - your leadership brings our mission to life. The best is yet to come!

🇩🇪 Wrapping up day 1 at the 14th Autumn Meeting of the German Molecular Pathology Working Group in Cologne, Germany! 🙏We would like to thank each and everyone who stopped by our booth and joined our symposium on "Advancing precision oncology with a matched tumor-normal approach: Real-World Experience of the Decentralized MSK-ACCESS® powered with SOPHiA DDM™ Liquid Biopsy Solution" presented by Dr. Verena Schramm, VP of Product Management at SOPHiA GENETICS. Didn't have the chance to meet us yet? Stop by our booth #A22 tomorrow and learn more about our latest advancements in oncology and how we empower clinical researchers and healthcare institutions globally to advance data-driven medicine. See you in Cologne! #DGP #HTMolPath2024 #MolecularPathology

Wrapping up a fantastic time at the Medical Genetics Congress in Turkey! Our VP of Product Management, Verena Schramm, delivered an exciting speech on "Building Evidence and Confidence in Liquid Biopsy Solutions" at the Satellite Symposium moderated by Dr. Kanay Yararbas. It’s moments like these that highlight our dedication to advancing data-driven medicine and innovation in genomic technologies. A big thank you to all attendees for driving meaningful conversations that shape the future of #healthcare! #DataDrivenMedicine #Innovation #Genomics

🧬 Day 1 at #ESMOAsia in Singapore wrapped up with great energy, and we’re excited for Day 2! For the first time, our APAC team is here to showcase how SOPHiA GENETICS is transforming #healthcare. 📍 Visit us at Booth #E406 over the next two days to explore innovative solutions like MSK-ACCESS® and MSK-IMPACT® powered with SOPHiA DDM™. Let’s connect, collaborate, and drive the future of healthcare innovation together. Come by and let’s chat! #ESMOAsia #NGS #Oncology #Innovation #PrecisionMedicine

🇺🇸 We’re heading to San Antonio, Texas, for the San Antonio Breast Cancer Symposium!   Our team is excited to join this renowned event, where groundbreaking breast cancer research and innovation take center stage. We’ll be connecting with #biopharma partners and discussing how multimodal data and analytics are transforming breast cancer research and care. 💬 Interested in meeting us at SABCS? Reach out to our team on LinkedIn: · Guillaume Cettou, Global Head of Data Partnerships · Marion Bossy, DVM, Global Head of RWE · Thierry Colin, VP, Multimodal R&D Let’s explore SOPHiA GENETICS’ innovation in breast cancer together!   #BreastCancerResearch #SABCS2024 #DataDrivenMedicine #MultimodalInnovation

Thank you to our speaker, Dr. Kojo Elenitoba-Johnson, Chair, Pathology and Laboratory Medicine at Memorial Sloan Kettering Cancer Center, and everyone who joined our corporate workshop at #AMP. It was a great opportunity to discover how MSK-IMPACT® powered with SOPHiA DDM™ is revolutionizing solid tumor profiling, improving somatic detection rates, and streamlining interpretation. 🔗 Learn more about MSK-IMPACT® powered with SOPHiA DDM™: https://lnkd.in/dvU-HiKx #DataDrivenMedicine #SolidTumors #PrecisionOncology